Literature DB >> 6423723

Reproductive hormone studies in three subjects with a Robertsonian translocation.

F Uccellatore, G Padova, S Squatrito.   

Abstract

The reproductive hormone function was investigated in three subjects, two brothers and one unrelated patient, with a Robertsonian translocation, who had come to us because of infertility. Basal levels of LH, FSH, testosterone, 17-beta-estradiol and prolactin were repeatedly measured by radioimmunoassays. In addition, clomiphene citrate, synthetic LH-RH, hCG and TRH tests were carried out. Karyotypes complemented by G-banding and C-banding, repeated semen analyses, and testicular biopsies were also obtained. The karyotype of all three subjects was 45, XY-13, -14, +t(13; 14) (p11; q11). Semen analyses showed oligozoospermia, and reduced or reduced/normal sperm motility. In addition, a high percentage of atypical forms was present in all three subjects. Reproductive hormone measurements in our three patients were substantially normal. Only one of the two brothers exhibited slightly low LH and testosterone levels. Both brothers also had elevated estradiol levels. Gonadotropin and testosterone responses to respective provocative stimuli, as well as prolactin elevation following TRH, were normal. In conclusion, the semen abnormalities observed in these three subjects with Robertsonian translocation appear to be responsible for their impaired fertility. However, the reason why some carriers of the same translocation are fertile and some others are subfertile or infertile remains unclear. It might be speculated that an individual genetic variability is responsible for different degrees of spermatogenic failure, accompanied, in more severe cases, also by reproductive hormone disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6423723     DOI: 10.1007/BF03348348

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Chromosome preparations of leukocytes cultured from human peripheral blood.

Authors:  P S MOORHEAD; P C NOWELL; W J MELLMAN; D M BATTIPS; D A HUNGERFORD
Journal:  Exp Cell Res       Date:  1960-09       Impact factor: 3.905

2.  A cytogenetic survey of men being investigated for subfertility.

Authors:  M J Faed; J Robertson; M A Lamont; W MacIntosh; J Grieve; K Baxby; G B James; A M Crowder
Journal:  J Reprod Fertil       Date:  1979-05

3.  Release of LH and FSH after administration of synthetic LH-releasing hormone.

Authors:  A J Kastin; A V Schally; C Gual; A Arimura
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

4.  Male infertility and 13-14 translocation.

Authors:  M Fraccaro; P Maraschio; F Pasquali; L Tiepolo; O Zuffardi; A Giarola
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

5.  Recurrent abortions and chromosome abnormalities.

Authors:  M Lucas; I Wallace; K Hirschhorn
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-12

6.  Short- and long-term effects of clomiphene citrate on the pituitary-testicular axis.

Authors:  R J Santen; J M Leonard; R J Sherins; H M Gandy; C A Paulsen
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

7.  Regulation of human gonadotropins. 3. Luteinizing hormone and follicle stimulating hormone in sera from adult males.

Authors:  N T Peterson; A R Midgley; R B Jaffe
Journal:  J Clin Endocrinol Metab       Date:  1968-10       Impact factor: 5.958

8.  Semen analysis in subfertile balanced-translocation carriers.

Authors:  D Marmor; J L Taillemite; J Van den Akker; M F Portnoi; N le Porrier; N Joye; D Delafontaine; C Roux
Journal:  Fertil Steril       Date:  1980-11       Impact factor: 7.329

9.  rDNA levels in infertile male carriers of Robertsonian translocations.

Authors:  G Guanti; O Zuffardi; L Tiepolo
Journal:  Cytogenet Cell Genet       Date:  1980

10.  Individual variation of centric heterochromatin in man.

Authors:  T Brown; F W Robertson; B M Dawson; S J Hanlin; B M Page
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.